Skip to Main Content

PALO ALTO, Calif. — Silicon Valley and the Bay Area have transformed commerce, technology, communications, and other fields, while also playing an outsized role in biomedical research. Can they find a formula to similarly disrupt and radicalize health care?

Part of the answer depends on public trust of tech giants. Part depends on the Food and Drug Administration, and how it might regulate data-driven products, such as artificial intelligence diagnostic tools that are becoming central to medical practice and drug development.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.